- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
AstraZeneca Pharma India Limited — Updates, 16-07-2026: General Updates
16-07-2026 | 02:38 pm
16-07-2026 | 02:38 pm
AstraZeneca Pharma India secured approval for its drug Fasenra® (Benralizumab) for an additional indication: treating Hypereosinophilic Syndrome (HES) in patients 12+. This expands the product's market reach in India.
No comments yet. Be the first to comment!